NCT00989664
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
Not specified
Clinical trial condition
Lymphoma, Non-Hodgkin
Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.
228 public trials
23 recruiting studies
Lymphoma, Non-Hodgkin trial results
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
Not specified
NCT01421667
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- City of Hope Duarte, California, United States
- PMK Medical Group Inc., DBA Ventura County Hematology Oncology Specialists Oxnard, California, United States
- Stanford Cancer Center Stanford, California, United States
NCT00996593
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
Not specified
NCT00025662
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +31 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
NCT00901069
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +7 more
- Locations
-
- University of Kentucky Lexington, Kentucky, United States
NCT00862719
- Conditions
- Acute Lymphoblastic Leukemia, Anemia, Anemia, Refractory, +26 more
- Locations
-
- IU Simon Cancer Center Indianapolis, Indiana, United States
NCT00117156
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- University of Rochester Cancer Center Rochester, New York, United States
Completed
Aflibercept and Standard Chemotherapy (R-CHOP) in First Line of Non Hodgkin B-cell Lymphoma
NCT00644124
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
- Sanofi-Aventis Administrative Office Paris, France
NCT02072967
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- City Clinical Hospital #8 Barnaul, Russia
- Chelyabinsk Regional Oncology Dispensary/15 Chelyabinsk, Russia
- Vologda Regional Clinical Hospital #2 Cherepovets, Russia
- Regional Oncology Dispensary/35 Irkutsk, Russia